Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

RLS Global

Less than 1K followers
All
Press releases
ShowingAll content types
Regulatory press release11/20/2023, 7:55 AM

RLS Global AB: RLS Global ansöker om konkurs

RLS Global
Regulatory press release11/9/2023, 9:15 PM

RLS Global AB: RLS Global initiates strategic review process aiming to commercialize ChloraSolv

RLS Global
Regulatory press release11/9/2023, 9:00 PM

RLS Global AB: RLS Global and Convatec have agreed to terminate collaboration agreement

RLS Global

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release9/6/2023, 7:00 AM

RLS Global AB: First patient included in new clinical investigation on pressure ulcers

RLS Global
Press release9/1/2023, 11:00 AM

RLS Global AB: ChloraSolv recommended for UK CA certification required for UK market after Brexit

RLS Global
Press release8/28/2023, 5:57 AM

Redeye: RLS Global Q2 2023 - Uncertain future

RLS Global
Regulatory press release8/25/2023, 7:00 AM

RLS Global AB: RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL-JUNE 2023

RLS Global
Regulatory press release8/24/2023, 4:30 PM

RLS Global AB: RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0

RLS Global
Regulatory press release8/22/2023, 1:00 PM

RLS Global AB: RLS Global appoints Torbjörn Sannerstedt as new Chief Financial Officer

RLS Global
Press release6/1/2023, 10:55 AM

Redeye: RLS Global Q1 2023: Delay in Europe but progress in the Middle East

RLS Global
Regulatory press release5/31/2023, 6:30 AM

RLS Global AB (publ) Interim Report, Q1, 2023

RLS Global
Press release3/20/2023, 10:00 AM

RLS Global AB: ChloraSolv shows notably greater antibiofilm activity in vitro compared to other debridement products in published article

RLS Global
Press release3/1/2023, 1:48 PM

Redeye: RLS Global Q4 2022 - No surprises – but expectations of an eventful 2023

RLS Global
Regulatory press release2/28/2023, 7:30 AM

RLS Global AB (publ) Year-end Report, Q4, 2022

RLS Global
Regulatory press release1/24/2023, 8:40 PM

Lars Johansson nominated as new Chairman of the Board of RLS Global AB

RLS Global
Press release12/9/2022, 8:00 AM

RLS Global AB: RLS Global: The rights issue is registered and the trading in Paid Subscription Shares ceases

RLS Global
Regulatory press release11/24/2022, 7:00 AM

RLS Global AB (publ) Interim Report, Q3, 2022

RLS Global
Regulatory press release11/14/2022, 9:45 PM

RLS Global AB: RLS Global: Outcome in RLS Global's rights issue

RLS Global
Press release11/10/2022, 10:00 AM

Presentation by Björn Larsson, CEO, RLS Global AB, about the company's operations and the currently ongoing rights issue

RLS Global
Press release11/4/2022, 1:30 PM

RLS Global AB: RLS Global's CEO Björn Larsson interviewed by Erik Penser Bank about the ongoing rights issue

RLS Global
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.